Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.
Harry Thomasian, Jr. net worth and biography

Harry Thomasian, Jr. Biography and Net Worth

CFO of Precigen
Mr. Harry Thomasian Jr. serves as the Chief Financial Officer for Precigen. Mr. Thomasian is a global finance leader with over 35 years of international business experience in equity and debt financings, P&L management and business operations, regulatory compliance and generally accepted accounting principles, SEC filings and Sarbanes-Oxley compliance. Prior to joining the company, Mr. Thomasian was with EY (formerly Ernst & Young LLP), one of the world’s largest global professional services firms. He most recently served as Senior Client Services Partner and the Baltimore Office Growth Markets Leader for the life sciences industry and Senior Partner in EY’s Capital Markets Center in Tokyo as well as other various global, area and local leadership positions. Mr. Thomasian earned a BS in Accountancy from Bentley University and completed the Ernst & Young Executive Development Program at the Kellogg School of Management, Northwestern University. Mr. Thomasian is licensed as a certified public accountant by the State Boards of Accountancy in Maryland, North Carolina, Washington, DC and Virginia.

How do I contact Harry Thomasian, Jr.?

The corporate mailing address for Mr. Thomasian, Jr. and other Precigen executives is 20374 Seneca Meadows Parkway, Germantown MD, 20876. Precigen can also be reached via phone at (301) 556-9900 and via email at [email protected] Learn More on Harry Thomasian, Jr.'s contact information.

Has Harry Thomasian, Jr. been buying or selling shares of Precigen?

Harry Thomasian, Jr. has not been actively trading shares of Precigen during the last quarter. Learn More on Harry Thomasian, Jr.'s trading history.

Who are Precigen's active insiders?

Precigen's insider roster includes Randal Kirk (Director), Donald Lehr (Insider), David Obstler (CFO), Jeffrey Perez (SVP), Helen Sabzevari (CEO), and Harry Thomasian, Jr. (CFO). Learn More on Precigen's active insiders.

Are insiders buying or selling shares of Precigen?

In the last year, Precigen insiders bought shares 1 times. They purchased a total of 24,500 shares worth more than $51,205.00. In the last year, insiders at the biotechnology company sold shares 5 times. They sold a total of 263,661 shares worth more than $372,468.96. The most recent insider tranaction occured on August, 23rd when CFO Harry Jr. Thomasian bought 24,500 shares worth more than $51,205.00. Insiders at Precigen own 43.7% of the company. Learn More about insider trades at Precigen.

Information on this page was last updated on 8/23/2022.

Harry Thomasian, Jr. Insider Trading History at Precigen

See Full Table

Harry Thomasian, Jr. Buying and Selling Activity at Precigen

This chart shows Harry Jr. Thomasian's buying and selling at Precigen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Precigen Company Overview

Precigen logo
Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
Read More

Today's Range

Now: $1.64
Low: $1.61
High: $1.70

50 Day Range

MA: $1.70
Low: $1.27
High: $2.19

2 Week Range

Now: $1.64
Low: $1.12
High: $2.90


4,320,856 shs

Average Volume

1,660,828 shs

Market Capitalization

$341.37 million

P/E Ratio


Dividend Yield



The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Click here to watch it, free.